Telos Biotechnology

At Telos Biotechnology, our most compelling point of traction is Telovance™, a proprietary protein complex designed to transform the cell and gene therapy landscape. 1. Breakthrough Technology: Telovance™ Telovance™ is a novel ancillary reagent that can be seamlessly integrated into both current and next-generation cell manufacturing processes. By preventing the rapid shortening of telomeres during ex vivo expansion, Telovance™ helps generate more robust, durable, and effective cell therapy products. 2. Broad Applicability Across Therapeutic Areas The versatility of Telovance™ positions it as a platform-enabling solution with applications spanning: - Cancer immunotherapy (e.g., CAR-T and beyond) – enhancing persistence and potency of engineered immune cells. - Autoimmune diseases – improving the durability of engineered regulatory immune cells. - Regenerative medicine – extending the functional lifespan of therapeutic cell populations. - Longevity and anti-aging – opening the door to rejuvenation strategies that improve cellular health. 3. Seamless Market Integration Unlike therapies requiring entirely new platforms, Telovance™ is designed as an ancillary reagent—a plug-and-play technology that can be adopted by a wide range of cell and gene therapy developers without disrupting their existing workflows. This dramatically lowers barriers to adoption while expanding its impact across multiple verticals. 4. Strategic Positioning in a High-Growth Market With the global cell and gene therapy market rapidly expanding, Telovance™ offers a unique, enabling technology that addresses a core limitation—telomere-driven cell exhaustion. This positions Telos Biotechnology not just as a therapy developer, but as a critical partner powering the next generation of curative treatments.